UAE’s Mubadala acquires shares worth $236mln in German pharmaceutical Evotec

UAE’s Mubadala acquires shares worth $236mln in German pharmaceutical Evotec

Mubadala Investment Company is pumping 200 million euros ($236 million)  into Evotec SE, a German pharmaceutical company that specialises in drug discovery solutions.Evotec SE said that it resolved a capital increase from its authorised capital without pre-emptive rights against cash. Evotec will issue a total of 11,478,298 new shares to Mubadala Investment Company and Novo Holdings A/S, increasing Evotec's cash reserves by €250 million ($295 million) in total, state news agency WAM reported.Evotec's existing shareholder Novo Holdings A/S also will invest €50 million to support Evotec's accelerated growth ambition and to reinforce its ownership in the company of approx. 11.0 percent of outstanding shares.Dr. Werner Lanthaler, Chief Executive Officer of Evotec, commented, "We welcome Mubadala to our group of strategic investors. There is no reason for us to slow down